You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia

    SBC: Irenix Medical, Inc.            Topic: NEI

    PROJECT SUMMARY / ABSTRACTThe objective of this Phase II proposal is to further develop a novel device for ocular anesthesia based on thermo-electric cooling. Intravitreal injection therapy (IVT) is one of the most commonly performed procedures in all of medicine, with approximately 7 million injections in the USA in 2016. Ocular anesthesia is required, both for patient safety and for tolerability ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  2. TOPIC 360: A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER

    SBC: DIAGNOLOGIX, LLC            Topic: NCI

    Chemotherapy may control but rarely cure metastatic cancers. Remarkably, modern immunotherapies, including cell-based therapies, have cured metastatic melanomas and other types of cancers. A major challenge for all cell therapies in general is the need to develop cost-effective and efficient manufacturing and delivery capabilities. We have recently established an innovative cell isolation technolo ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  3. Prospective evaluation of a surgical solution for breast cancer-associated lymphedema

    SBC: Fibralign Corporation            Topic: 102

    Project Summary/Abstract Prospective evaluation of a surgical solution for breast cancer-associated lymphedema The proposed project will complete remaining key research and technology requirements that are needed to commercialize a ground-breaking interventional device for treating secondary lymphedema -- a chronic and debilitating disease that currently has no cure and impacts an estimated 15-30% ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  4. Data-Parallel Analytics on Graphics Processing Units (GPUs)

    SBC: Royal Caliber            Topic: ST13B004

    We are proposing to enable automated discovery of machine learning pipelines on graphs using our system of accelerated primitives. While our existing technology greatly reduces the need for users to understand super-computing, it still requires expertis...

    SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  5. Scalable Wideband Autonomous RF Mapping MANET

    SBC: Silvus Technologies, Inc.            Topic: SB162011

    Electromagnetic spectrum (EMS) awareness continues to be a critical capability for military dominance in the field. The number, dynamics, and types of sources in an increasingly congested RF spectrum has shifted the focus of DoD research away from large ...

    SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  6. Managing Emergent Behavior of Interacting Autonomous Systems

    SBC: BOSTON FUSION CORP            Topic: SB162005

    The team of Boston Fusion Corp. and Arizona State University proposes Phase II of Autonomous System Control via Social Insect Models (ASC-SIM). ASC-SIM provides a unified framework that combines: swarm-based scenarios of national interest; predictive soc...

    SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  7. Biologically-Inspired Swarm pErception and Control Technology (BISECT)

    SBC: SCIENTIFIC SYSTEMS CO INC            Topic: SB162005

    Biologically-Inspired Swarm pErception and Control Technology (BISECT) is a decentralized swarm autonomy framework that enables effective management of emergent behaviors amid neutral or adversarial multi-swarm interactions. One key BISECT capability is ...

    SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency
  8. Complex Networks for Computational Urban Resilience (CONCUR)

    SBC: Perceptronics Solutions, Inc.            Topic: ST17C003

    CONCUR develops a computational framework for assessing and characterizing urban environments stability or fragility in response to volatility and stress, identifying specific weaknesses as well as key tipping points which could lead to rapid systemic failure. CONCUR explicitly models urban environments as emergent complex systems, focusing attention on the critical triggers that could lead to rap ...

    STTR Phase I 2018 Department of DefenseDefense Advanced Research Projects Agency
  9. Topic 377: Bridging the Guideline Implementation Gap: Clinical Decision Support to Improve Cancer Symptom Management

    SBC: Cognitive Medical Systems, Inc.            Topic: NCI

    Advances in clinical research have yielded many evidence-based guidelines to help clinicians provide the right care for the right patient at the right time; however, studies suggest that nearly half the time, that care does not reach the patient. Clinical decision support (CDS) is an information technology-enabled method to identify missed opportunities and optimize care. This proposal seeks to sy ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Topic 371: Validation and Optimization of RP-185 as Adjuvant to Exploit the Immune Response Generated by Radiation

    SBC: Riptide Bioscience, Inc.            Topic: NCI

    Radiotherapy, a key anticancer therapy, acts not only by killing cancer cells, but also by activating the body's immune system to attack the remaining cancer cells. However, the immune-stimulating effect is weakened by the tumor's capacity to reprogram immune cells, particularly macrophages, so that they instead actively promote tumor growth. RP-185 (Riptide Biosciences, Vallejo, CA),an engineered ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government